First targeted therapy for rare mutation of gastrointestinal stromal tumors
The U.S. Food and Drug Administration (FDA) recently announced the approval of Blueprint Medicines Corporation’s avapritinib (Ayvakit) for the treatment…
News
Linguistics in healthcare: Why it matters
MK Hedrick is a former colleague of mine who works in healthcare market research. When we worked together, we were…
Deaths from coronavirus rise
In the past 24 hours, news coverage of the coronavirus in Wuhan, China has become more and more rampant. I…
First coronavirus patient identified in U.S.
On the heels of today’s earlier post regarding the increase mortality rates in Wuhan, China from the coronavirus, The New York…
New findings from the American Cancer Society on reduced cancer mortality rates
Based on new findings from a 2020 American Cancer Society report, mortality rates from cancer have declined by 29% between…